ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

IMRX Immuneering Corporation

1.35
-0.03 (-2.17%)
2024年6月5日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Immuneering Corporation IMRX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.03 -2.17% 1.35 07:10:01
始値 安値 高値 終値 前日終値
1.35 1.32 1.38 1.34 1.38
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/3005:05GLOBEImmuneering to Present at the Jefferies Global Healthcare..
2024/5/2405:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2405:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2405:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2405:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2405:10EDGAR2Form 8-K - Current report
2024/5/0805:05GLOBEImmuneering Reports First Quarter 2024 Financial Results and..
2024/5/0805:04EDGAR2Form 8-K - Current report
2024/5/0705:30GLOBEImmuneering Recognizes Melanoma Awareness Month
2024/4/1001:00GLOBEIMM-1-104 is Synergistic with Chemotherapy in Pancreatic..
2024/4/0405:05GLOBEImmuneering to Participate in the 23rd Annual Needham..
2024/3/2721:00GLOBEImmuneering Announces First Patient Dosed in its Phase 1/2a..
2024/3/1420:00GLOBEImmuneering Announces Positive Topline Results from Phase 1..
2024/3/1221:00GLOBEImmuneering Appoints Thomas J. Schall, Ph.D. to its Board of..
2024/3/1121:00GLOBEImmuneering Doses First Patient in Phase 2a Clinical Trial..
2024/3/0607:00GLOBEImmuneering to Present Preclinical Data on Universal-RAS..
2024/3/0422:00GLOBEImmuneering to Participate in the Cowen 44th Annual Health..
2024/3/0122:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0122:00GLOBEImmuneering Reports Fourth Quarter and Full Year 2023..
2024/3/0121:58EDGAR2Form 8-K - Current report
2024/2/2022:00GLOBEImmuneering Receives FDA Fast Track Designation for..
2024/2/1006:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1006:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1006:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1006:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1006:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1006:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:15EDGAR2Form 8-K - Current report
2024/1/1706:37EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/0306:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1222:00GLOBEImmuneering Announces FDA Clearance of IND Application for..
2023/11/2106:05GLOBEImmuneering to Present at the 35th Annual Piper Sandler..
2023/11/1006:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1006:05GLOBEImmuneering Reports Third Quarter 2023 Financial Results and..
2023/10/1305:05GLOBEImmuneering Presents Preclinical Data Demonstrating..
2023/10/0505:05GLOBEImmuneering to Present Preclinical Data on IMM-1-104 and..
2023/9/0621:00GLOBEImmuneering to Present at the Morgan Stanley Healthcare..
2023/8/0405:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0405:05GLOBEImmuneering Reports Second Quarter 2023 Financial Results..
2023/8/0405:04EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock